Medtronic Medical Device Recall |
Article: Lawsuits Continue Over Medtronic’s Off Label Marketing Of Infuse Bone GraftLawsuits against Medtronic continue over its Infuse Bone Graft product. The medical device giant is being accused of marketing the product for off label uses not approved by the U.S. Food and Drug Administration (FDA).
Product liability lawsuits filed According to news reports, product liability lawsuits have been filed against Medtronic for promoting off label uses of its Infuse Bone Graft, a liquid bone simulator. The product was approved for lumbar spine and dental procedures, but the company has allegedly been marketing the product for use in the cervical spine as well – something which the FDA has not approved. The latter has caused patients serious injuries and three lawsuits have already been filed against the company. Details of the lawsuits Three lawsuits, in California, Texas and New York, have been filed against Medtronic to date and legal analysts say that additional lawsuits are likely. Here are the details of those cases:
Whistleblower lawsuit In addition to the lawsuits described above, a whistleblower – or Qui Tam – lawsuit was also filed against Medtronic in January of 2009 alleging that the company entered into secret agreements with doctors to use its Infuse Bone Graft product. If you’ve been injured due to a defective or dangerous product, contact an experienced products liability attorney to discuss your case and evaluate your options. Consultations with an attorney are free, without obligation and are strictly confidential. Articles & Information:Medtronic Recalls Fidelis Defibrillators from Market Medtronic Defibrillator Leads Linked To Five Deaths Medtronic Defibrillator Recall Causing Consumer Panic Medtronic Urges 235,000 Defibrillator Patients to See Doctors View all articles |